This drug also treats a health issue affecting more than 50% of a certain group—here's the unusual reason it's under recall.
While 2025 research revealed that only around half of the people who need to take cholesterol medications actually do, hypertension is arguably better managed since blood pressure is a vital that’s checked at most doctor appointments.
But for consumers who take a particular blood pressure drug, a recall drug will be relevant. In a Wednesday, February 11 report, the U.S. Food and Drug Administration (FDA) announced that 60,000 doxazosin tablets had been recalled on January 21.
The reason for the recall, according to the FDA, is “Tablets/Capsules Imprinted with Wrong ID.” The National Archives Code of Federal Regulations explains that the FDA requires imprinting on solid oral dosage drugs for “unique identification,” such as in the production and pharmacy settings. It’s unclear how the doxazosin tablets were incorrectly marked.
The doxazosin was reportedly distributed by New Jersey-based Unichem Pharmaceuticals, whose India branch manufactured the drug. Identifying details are said to include the following:
Doxazosin Tablets, USP
- 1000-count tablets per bottle
- 4 milligram (mg) dosage
- NDC (National Drug Code) 29300-353-10
- Lot # GDSH25006
- Exp Date: 08/2027
The February 11 report announced that the event had been assigned as a Class III recall, defined as “a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.”
The Mayo Clinic explains that doxazosin “is used to treat high blood pressure” and “benign (noncancerous) enlargement of the prostate (benign prostatic hyperplasia …).” The explanation, respectively, is that the drug helps relax the blood vessels and the prostate muscles.
In the U.S., approximately 50% of men over 50 experience prostate enlargement, with the prevalence and probability increasing with age.
For daily wellness updates, subscribe to The Healthy newsletter and follow The Healthy on Facebook and Instagram. Keep reading:
